Retinal pigment epithelial tears and the management of exudative age-related macular degeneration

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 94-103

  Barkmeier, Andrew J ^a   Carvounis, Petros E ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

age related macular degeneration; bevacizumab; pigment epithelial detachment; ranibizumab; retinal pigment epithelial (RPE) rip; retinal pigment epithelial (RPE) tear; vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN; VERTEPORFIN;

AGE; ARGON LASER; ARTICLE; BRUCH MEMBRANE; DISEASE COURSE; DISEASE SEVERITY; DRUSEN; ENHANCED DEPTH IMAGING; EXUDATIVE MACULAR DEGENERATION; HUMAN; HYDROSTATIC PRESSURE; IMAGING; INTRAOCULAR PRESSURE ABNORMALITY; KRYPTON LASER; LASER COAGULATION; MECHANICAL STRESS; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; EXUDATES AND TRANSUDATES; HUMANS; MACULAR DEGENERATION; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; RUPTURE, SPONTANEOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79957625975     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2011.571055     Document Type: Article

References (70)

1. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthlamol. 1981; 65: 417-422. (Pubitemid 11046373)
2. Yeo JH, Marcus S, Murphy RP. Retinal pigment epithelial tears. Ophthalmology. 1988; 95:8-13.
3. Decker WL, Sanborn GE, Ridley M, et al. Retinal pigment epithelial tears. Ophthalmology. 1983; 90:507-512 (Pubitemid 13059779)
4. Gass JDM. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol. 1984; 68:513-519. (Pubitemid 15135455)
5. Emerson GG, Ghazi NG. Spontaneous rip of the retinal pigment epithelium with a macular hole in neovascular age-related macular degeneration. Am J Ophthalmol. 2005; 140(2):316-318. (Pubitemid 41125818)
6. Bressler NM, Finklestein D, Sunness JS, et al. Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol. 1990; 108:1694-1697.
7. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye. 1988; 2:106-113. (Pubitemid 18086048)
8. Arroyo JG, Schatz H, McDonald R, Johnson RN. Indocyanine green videoangiography after acute retinal pigment epithelial tears in age-related macular degeneration. Am J Ophthalmol. 1997; 123:377-385. (Pubitemid 27123045)
9. Giovannini A, Amato G, Mariotti C, et al. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina. 2000; 20:37-40. (Pubitemid 30387463)
10. Karadimas P, Paleokastritis GP, Bouzas EA. Fundus autofluorescence imaging findings in retinal pigment epithelial tear. Euro J Ophthalmol. 2006; 16(5):767-769. (Pubitemid 44870766)
11. Gass JDM. Serous retinal pigment epithelial detachment with a notch. Retina. 1984; 4:205-220.
12. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009; 147:644-652.
13. Lafaut BA, Aisenbrey S, Vanden Broecke C, et al. Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol. 2001; 85:454-460. (Pubitemid 32275628)
14. Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol. 1985; 100:698-707. (Pubitemid 16206941)
15. Hartnett ME, Lappas A, Darland D, et al. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGFdependent mechanism. Exp Eye Res. 2003; 77:593-99. (Pubitemid 37188734)
16. Ghassemifar R, Lai CM, Rakoczy PE. VEGF differentially regulates transcription and translation of ZO-1a+ and ZO-1a- in cultured endothelial and epithelial cells. Cell Tissue Res. 2006; 323:117-125.
17. Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007; 85:762-71. (Pubitemid 350166363)
18. Peng S, Adelman RA, Rizzolo LJ. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci. 2010; 51(6):3216-25.
19. Miura Y, Klettner A, Roider J. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: Possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci. 2010; 51(9):4848-55.
20. Meyer CH, Toth CA. Retinal pigment epithelial tear with vitreomacular detachment: A novel pathogenic feature. Graefe's Arch Clin Exp Ophthalmol. 2001; 239:235-333.
21. Levin LA, Seddon JM, Topping T. Retinal pigment epithelial tears associated with trauma. Am J Ophthalmol. 1991; 112(4):396-400.
22. Chuang EL, Bird AC. The pathogenesis of tears of the retinal pigment epithelium. Am J Ophthalmol. 1988; 105:285-290. (Pubitemid 18078112)
23. Toth CA, Pasquale AC, Graichen DF. Clinicopathologic correlation of spontaneous retinal pigment epithelial tears with choroidal neovascular membranes in age-related macular degeneration. Ophthalmology. 1995; 102:272-277.
24. Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci. 1997; 38:762-767. (Pubitemid 27143147)
25. Chuang EL, Bird AC. Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol. 1988; 72:918-920. (Pubitemid 19022867)
26. Schoeppner G, Chuang EL, Bird AC. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol. 1989; 108:683-685. (Pubitemid 20013090)
27. Kroyer K, la Cour M, Larsen M. Dissociation of rod and cone sensitivity by acute localized retinal pigment epithelium loss. Acta Ophthalmol. 2008; 86:338-340. (Pubitemid 351785107)
28. Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin A in cone-dominant retinas: A novel pathway for visual-pigment regeneration in daylight. Neuron. 2002; 36(1):69-80.
29. Iijima H, Gohdo T. Visual field change in eyes with retinal pigment epithelial tear. Retina. 1999; 19:198-203. (Pubitemid 30368134)
30. Maguire JI, Annesley WH, Decker WL, et al. Computerised visual field deficits in tears of the retinal pigment epithelium. Br J Ophthalmol. 1990; 74:556-558. (Pubitemid 20265404)
31. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: Classification and outcome. Br J Ophthalmol. 1985; 69:397-403. (Pubitemid 15059051)
32. Pauleikhoff D, Loffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefe's Arch Clin Exp Ophthalmol. 2002; 240:533-538. (Pubitemid 36097080)
33. Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments: A study of 40 eyes. Arch Ophthalmol. 1990; 108:1687-1693.
34. Barondes MJ, Pagliarini S, Chisholm IH, et al. Controlled trial of laser photocoagulation of pigment epithelial detatchments in the elderly: 4 year review. Br J Ophthalmol. 1992; 76:5-7.
35. Gass JDM. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol. 1984; 98:700-706. (Pubitemid 15219227)
36. Thompson JT. Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization. Am J Ophthalmol. 2001; 131(5):662-664. (Pubitemid 32422131)
37. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina. 2001; 21(6):661-665. (Pubitemid 34027784)
38. Gelisken F, Inhoffen W, Partsch M, et al. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol. 2001; 131:518-520. (Pubitemid 32273446)
39. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye. 2005; 19:1315-1324. (Pubitemid 43148509)
40. Michels S, Aue A, Simader C, et al. Retinal pigment epithelium tears following verteporphin therapy combined with intravitreal triamcinolone. Am J Ophthalmol. 2006; 141:396-398.
41. Lommatzsch A, Heimes B, Gutfleisch M, et al. Serous pigment epithelial detachment in age related macular degeneration: Comparison of different treatments. Eye. 2009; 23:2163-2168.
42. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGFassociated retinal pigment epithelial tear using FA and OCT analysis. Retina. 2008; 28:1265-1269.
43. Dhalla MS, Blinder KJ, Tewari A, et al. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol. 2006; 141:752-754.
44. Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina. 2007; 27:857-863. (Pubitemid 47479380)
45. Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol. 2006; 142:160-162. (Pubitemid 43946807)
46. Shah CP, Hsu J, Garg SJ, et al. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol. 2006; 142:1070-1071.
47. Arias L, Caminal JM, Rubio M, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol. 2007; 17(6):992-995. (Pubitemid 351262915)
48. Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularized PED secondary to AMD. Graefe's Arch Clin Exp Ophthalmol. 2007; 245:1037-1040.
49. Weinberger AWA, Thiel M, Mohammadi B, et al. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Am J Ophthalmol. 2007; 144:294-296. (Pubitemid 47094707)
50. Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe. 2008; 105:158-164.
51. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularization secondary to age related macular degeneration. Br J Ophthalmol. 2006; 90:1207-1208. (Pubitemid 44351161)
52. Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2007; 27:535-540. (Pubitemid 46905142)
53. Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina. 2007; 27:541-551. (Pubitemid 46905143)
54. Chang LK, Sarraf D. Tears of the retinal pigment epithelium. An old problem in a new era. Retina. 2007; 27:523-534. (Pubitemid 46905141)
55. Garg S, Brod R, Kim D, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative agerelated macular degeneration. Clin and Exp Ophthalmol. 2008; 36:252-256. (Pubitemid 351560274)
56. Forooghian F, Cukras C, Chew EY. Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment. Can J Ophthalmol. 2008; 43(2):246-248. (Pubitemid 351518187)
57. Leitreitz M, Gelisken F, Inhoffen W, et al. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye. 2008; 22:1504-1507.
58. Gelisken F, Ziemssen F, Voelker M, et al. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye. 2009; 23:694-702.
59. Moroz I, Moisseiev J, Alhalel A. Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. Ophthalmic Surg Lasers Imaging. 2009; 40:570-575.
60. Chan CK, Abraham P, Meyer CH, et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina. 2010; 30(2):203-11.
61. Wong LJ, Desai RU, Jain A, et al. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina. 2008; 28:1151-1158.
62. Spandau UHM, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2006; 142:1068-1070. (Pubitemid 44853878)
63. Smith BT, Kraus CL, Apte RS. Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina. 2009; 29:335-339.
64. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative agerelated macular degeneration. Am J Ophthalmol. 2007; 143:504-505.
65. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol. 2007; 143:505-507. (Pubitemid 46273349)
66. Kiss C, Michels S, Prager F, et al. Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol. Scand. 2007; 85:902-903. (Pubitemid 350142817)
67. Konstantinidis L, Ambresin A, Zografos L, Mantel I. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol Scand. 2010; 88(7):736-41.
68. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355:1419-1431. (Pubitemid 44511557)
69. Sarraf D, Reddy S, Chiang A, et al. A new grading system for retinal pigment epithelial tears. Retina. 2010; 30:1039-1045.
70. Polito A, Cereda M, Romanelli F, Pertile G. Macular translocation with 360° retinotomy for management of retinal pigment epithelial tear: Long-term results. Br J Ophthalmol. 2011; 95(1):74-8.